Kichukova D, Milchev N, Paskaleva V, Malinova M
Akush Ginekol (Sofiia). 1998;37(2):4-6.
Every obstetrician is acquainted with the existing risk during the placental stage. The danger of a greater blood loss is always present. The use of uterotonic medicines reduces the post-delivery bleeding. The authors have carried out observations over 422 delivery cases. In 153 of them ergotamine has been applied in the placental stage, in 121 oxytocine, and in 148 delivery cases the placental stage has passed without uterotonic drugs. The authors have concluded that the application of contracting medicines reduces the blood loss, but their usage has to be selective and after delivery of the fore shoulder of the foetus.
每位产科医生都熟知胎盘娩出期存在的风险。大出血的危险始终存在。使用宫缩剂可减少产后出血。作者对422例分娩病例进行了观察。其中153例在胎盘娩出期应用了麦角胺，121例应用了催产素，148例分娩病例在胎盘娩出期未使用宫缩剂。作者得出结论，应用宫缩剂可减少失血，但必须有选择性地使用，且应在胎儿前肩娩出后使用。
